| Branched‐chain amino acids for people with hepatic encephalopathy LL Gluud, G Dam, I Les, G Marchesini, M Borre, NK Aagaard, H Vilstrup Cochrane Database of Systematic Reviews, 2015 | 628* | 2015 |
| Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites G Dam, H Vilstrup, H Watson, P Jepsen Hepatology 64 (4), 1265-1272, 2016 | 200 | 2016 |
| Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials LL Gluud, G Dam, M Borre, I Les, J Cordoba, G Marchesini, NK Aagaard, ... The Journal of nutrition 143 (8), 1263-1268, 2013 | 154 | 2013 |
| Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? LL Gluud, G Dam, M Borre, I Les, J Cordoba, G Marchesini, NK Aagaard, ... Metabolic brain disease 28, 221-225, 2013 | 132 | 2013 |
| Branched-chain amino acids and muscle ammonia detoxification in cirrhosis G Dam, P Ott, NK Aagaard, H Vilstrup Metabolic brain disease 28, 217-220, 2013 | 99 | 2013 |
| Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake G Dam, S Keiding, OL Munk, P Ott, H Vilstrup, LK Bak, ... Hepatology 57 (1), 258-265, 2013 | 85 | 2013 |
| Resistance training increases muscle strength and muscle size in patients with liver cirrhosis L Aamann, G Dam, M Borre, A Drljevic-Nielsen, K Overgaard, H Andersen, ... Clinical Gastroenterology and Hepatology 18 (5), 1179-1187. e6, 2020 | 76 | 2020 |
| Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects G Dam, S Keiding, OL Munk, P Ott, M Buhl, H Vilstrup, LK Bak, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 301 (2 …, 2011 | 71 | 2011 |
| Physical exercise for people with cirrhosis L Aamann, G Dam, AR Rinnov, H Vilstrup, LL Gluud Cochrane Database of Systematic Reviews, 2018 | 52 | 2018 |
| Update on the therapeutic management of hepatic encephalopathy LS Kornerup, LL Gluud, H Vilstrup, G Dam Current gastroenterology reports 20, 1-6, 2018 | 46 | 2018 |
| Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms ET Janson, U Knigge, G Dam, B Federspiel, H Grønbaek, P Stålberg, ... Acta Oncologica 60 (7), 931-941, 2021 | 42 | 2021 |
| Nutritional status and nutritional risk in patients with neuroendocrine tumors M Borre, GA Dam, AW Knudsen, H Grønbaek Scandinavian journal of gastroenterology 53 (3), 284-292, 2018 | 42 | 2018 |
| The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy G Dam, L Aamann, H Vistrup, LL Gluud Journal of clinical and experimental hepatology 8 (4), 448-451, 2018 | 40 | 2018 |
| von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance MLM Binderup, M Smerdel, L Borgwadt, SSB Nielsen, MG Madsen, ... European Journal of Medical Genetics 65 (8), 104538, 2022 | 37 | 2022 |
| Muscle metabolism and whole blood amino acid profile in patients with liver disease G Dam, M Sørensen, M Buhl, TD Sandahl, N Møller, P Ott, H Vilstrup Scandinavian journal of clinical and laboratory investigation 75 (8), 674-680, 2015 | 33 | 2015 |
| Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small-intestinal, and unknown primary neuroendocrine tumors G Dam, H Grønbæk, H Sorbye, E Thiis Evensen, B Paulsson, A Sundin, ... Neuroendocrinology 110 (3-4), 217-224, 2020 | 31 | 2020 |
| Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites G Dam, H Vilstrup, PK Andersen, L Bossen, H Watson, P Jepsen Liver International 39 (3), 514-521, 2019 | 29 | 2019 |
| Protein tolerance to standard and high protein meals in patients with liver cirrhosis O Campollo, D Sprengers, G Dam, H Vilstrup, N McIntyre World Journal of Hepatology 9 (14), 667, 2017 | 29 | 2017 |
| Brain edema: a valid endpoint for measuring hepatic encephalopathy? C Bémeur, C Cudalbu, G Dam, AS Thrane, AJL Cooper, CF Rose Metabolic brain disease 31, 1249-1258, 2016 | 27 | 2016 |
| Cerebral water content mapping in cirrhosis patients with and without manifest HE M Winterdahl, Z Abbas, O Noer, KL Thomsen, V Gras, A Nahimi, ... Metabolic brain disease 34, 1071-1076, 2019 | 17 | 2019 |
Luise Aamann, MD, PhDDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, DenmarkVerified email at regionh.dk
